Publications Methods for handling missing segments in Crohn’s disease clinical trials: analysis from the EXTEND trial Citation Ma C, Khanna R, Guizzetti L, Zou G, Feagan BG, Jairath V. Methods for handling missing segments in Crohn's disease clinical trials: analysis from the EXTEND trial. Gut. 2022 Feb;71(2):447-448. doi: 10.1136/gutjnl-2021-324658. Epub 2021 May 6. PMID: 33958434. Abstract Conflict of interest statement Competing interests: CM has received consulting fees from AbbVie, Amgen, AVIR Pharma, Janssen, Ferring, Fresenius Kabi, Takeda, Pfizer, Roche and Alimentiv (formerly Robarts Clinical Trials); speaker’s fees from AbbVie, Janssen, Takeda and Pfizer; and research support from Pfizer. Tags Biostatistics, Clinical Trials, Crohn's Disease, Drug Therapy Read More
